Monocytes and Neutrophils Oxidize Low Density Lipoprotein Making It Cytotoxic
暂无分享,去创建一个
[1] G. Chikkappa,et al. Very low density lipoprotein hematopoiesis inhibitor from rat plasma. , 1980, Experimental hematology.
[2] D. Goodman,et al. Inhibition of lymphocyte proliferation stimulated by lectins and allogeneic cells by normal plasma lipoproteins , 1977, The Journal of experimental medicine.
[3] T. Pollard,et al. Isolation and properties of phagocytic vesicles from polymorphonuclear leukocytes. , 1971, The Journal of clinical investigation.
[4] R. Keller. Susceptibility of normal and transformed cell lines to cytostatic and cytocidal effects exerted by macrophages. , 1976, Journal of the National Cancer Institute.
[5] K. Yagi,et al. Reaction of linoleic acid hydroperoxide with thiobarbituric acid. , 1978, Journal of lipid research.
[6] C. B. Taylor,et al. Cytotoxicity of oxidation derivatives of cholesterol on cultured aortic smooth muscle cells and their effect on cholesterol biosynthesis. , 1979, The American journal of clinical nutrition.
[7] S. Hinuma,et al. Pretreatment of plastic Petri dishes with fetal calf serum. A simple method for macrophage isolation. , 1979, Journal of immunological methods.
[8] D. Steinberg,et al. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[9] J L Witztum,et al. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[10] S. Zucker,et al. Rat hematopoietic cell receptors for very low density lipoprotein (VLDL) growth inhibitor. , 1981, Experimental hematology.
[11] A. Gotto,et al. Correlation of apolipoprotein B retention with the structure of atherosclerotic plaques from human aortas. , 1978, Laboratory investigation; a journal of technical methods and pathology.
[12] P. Ward,et al. Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. , 1982, The American journal of pathology.
[13] B. Arbogast,et al. In Vitro Injury of Porcine Aortic Endothelial Cells by Very-Low-Density Lipoproteins from Diabetic Rat Serum , 1982, Diabetes.
[14] I. Fidler,et al. Tumoricidal activity of human monocytes activated in vitro by free and liposome-encapsulated human lymphokines. , 1983, The Journal of clinical investigation.
[15] L. J. Lewis,et al. Lipoprotein Oxidation and Lipoprotein‐lnduced Cytotoxicity , 1983, Arteriosclerosis.
[16] S. Chan,et al. In vitro effects of lipoprotein-associated cytotoxic factor on rat prostate adenocarcinoma cells. , 1978, Cancer research.
[17] R. Gerrity,et al. Localization of LDL in Arteries: Improvements in Immunofluorescence Procedures a , 1983, Annals of the New York Academy of Sciences.
[18] D. Morel,et al. Low density lipoprotein (LDL) becomes cytotoxic after in vitro oxidation by phagocyte-derived free radicals , 1984 .
[19] J. Hibbs. Macrophage Nonimmunologic Recognition: Target Cell Factors Related to Contact Inhibition , 1973, Science.
[20] T. Henriksen,et al. Injury to human endothelial cells in culture induced by low density lipoproteins. , 1979, Scandinavian journal of clinical and laboratory investigation.
[21] M L KARNOVSKY,et al. The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes. , 1959, The Journal of biological chemistry.
[22] O. D. Taunton,et al. Inhibition of lymphoproliferation by hyperlipoproteinemic plasma. , 1976, The Journal of clinical investigation.
[23] F. Wróblewski,et al. Lactic Dehydrogenase Activity in Blood.∗ , 1955, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[24] A. Novogrodsky,et al. Inhibition of lymphocyte mitogenesis by autoxidized low-density lipoprotein. , 1978, Biochemical and biophysical research communications.
[25] G. Chisolm,et al. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. , 1979, Atherosclerosis.
[26] A. Gotto,et al. Abnormal effects of hypertriacylglycerolemic very low-density lipoproteins on 3-hydroxy-3-methylglutaryl-CoA reductase activity and viability of cultured bovine aortic endothelial cells. , 1980, Biochimica et biophysica acta.
[27] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[28] Weiss Sj,et al. Phagocyte-generated oxygen metabolites and cellular injury , 1982 .
[29] D. Gospodarowicz,et al. Effect of high and low density lipoproteins on proliferation of cultured bovine vascular endothelial cells. , 1980, The Journal of clinical investigation.
[30] D. Morel,et al. Endothelial and Smooth Muscle Cells Alter Low Density Lipoprotein In Vitro by Free Radical Oxidation , 1984, Arteriosclerosis.
[31] Y. Masamune,et al. Reversible inhibition by human serum lipoproteins of cell proliferation , 1982, Journal of cellular physiology.
[32] S. Chan,et al. Characterization of a very-low-density lipoprotein (VLDL)-associated cytotoxic factor. , 1981, British Journal of Cancer.
[33] R H Haschemeyer,et al. Oxygen-mediated heterogeneity of apo-low-density lipoprotein. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[34] D. Morel,et al. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. , 1983, Journal of lipid research.
[35] P. Trinder. Determination of Glucose in Blood Using Glucose Oxidase with an Alternative Oxygen Acceptor , 1969 .